Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection
K Samaras - Journal of Antimicrobial Chemotherapy, 2008 - academic.oup.com
The use of highly active antiretroviral therapy (HAART) in HIV-1 infection confers
immunological and survival advantages, at the cost of induction of significant metabolic …
immunological and survival advantages, at the cost of induction of significant metabolic …
Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection
K Samaras - Journal of Antimicrobial Chemotherapy, 2008 - search.ebscohost.com
The use of highly active antiretroviral therapy (HAART) in HIV-1 infection confers
immunological and survival advantages, at the cost of induction of significant metabolic …
immunological and survival advantages, at the cost of induction of significant metabolic …
Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection.
K Samaras - The Journal of Antimicrobial Chemotherapy, 2007 - europepmc.org
The use of highly active antiretroviral therapy (HAART) in HIV-1 infection confers
immunological and survival advantages, at the cost of induction of significant metabolic …
immunological and survival advantages, at the cost of induction of significant metabolic …
Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection.
K Samaras - 2008 - cabidigitallibrary.org
The use of highly active antiretroviral therapy (HAART) in HIV-1 infection confers
immunological and survival advantages, at the cost of induction of significant metabolic …
immunological and survival advantages, at the cost of induction of significant metabolic …
Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection
K Samaras - Journal of Antimicrobial Chemotherapy, 2008 - elibrary.ru
The use of highly active antiretroviral therapy (HAART) in HIV-1 infection confers
immunological and survival advantages, at the cost of induction of significant metabolic …
immunological and survival advantages, at the cost of induction of significant metabolic …
Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection
K Samaras - The Journal of antimicrobial chemotherapy, 2008 - pubmed.ncbi.nlm.nih.gov
The use of highly active antiretroviral therapy (HAART) in HIV-1 infection confers
immunological and survival advantages, at the cost of induction of significant metabolic …
immunological and survival advantages, at the cost of induction of significant metabolic …
[PDF][PDF] Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection
K Samaras - Journal of Antimicrobial Chemotherapy, 2008 - Citeseer
The use of highly active antiretroviral therapy (HAART) in HIV-1 infection confers
immunological and survival advantages, at the cost of induction of significant metabolic …
immunological and survival advantages, at the cost of induction of significant metabolic …
[引用][C] Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection
K SAMARAS - Journal of antimicrobial chemotherapy (Print), 2008 - pascal-francis.inist.fr
Metabolic consequences and therapeutic options in highly active antiretroviral therapy in
human immunodeficiency virus-1 infection CNRS Inist Pascal-Francis CNRS Pascal and …
human immunodeficiency virus-1 infection CNRS Inist Pascal-Francis CNRS Pascal and …